Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended fosfomycin use for uncomplicated cystitis in primary care
NL-OMON50944Phase 4Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fosfomycin and nitrofurantoin in cystitis and urinary tract infection (UTI) (3 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Duration of cystitis symptoms. Started Oct 2021; status: active, not recruiting.
02
Drugs
fosfomycinnitrofurantoin
03
Conditions
cystitisurinary tract infection (UTI)
Beyond the preview
Go deeper on NL-OMON50944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50944.